These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38340475)

  • 21. In search of uracil derivatives as bioactive agents. Uracils and fused uracils: Synthesis, biological activity and applications.
    Pałasz A; Cież D
    Eur J Med Chem; 2015 Jun; 97():582-611. PubMed ID: 25306174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioactive Peptide Natural Products as Lead Structures for Medicinal Use.
    Dang T; Süssmuth RD
    Acc Chem Res; 2017 Jul; 50(7):1566-1576. PubMed ID: 28650175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of click chemistry towards an efficient synthesis of 1,2,3-1H-triazolyl glycohybrids as enzyme inhibitors.
    Anand N; Jaiswal N; Pandey SK; Srivastava AK; Tripathi RP
    Carbohydr Res; 2011 Jan; 346(1):16-25. PubMed ID: 21129735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromone Containing Hybrid Analogs: Synthesis and Applications in Medicinal Chemistry.
    Auti PS; Jagetiya S; Paul AT
    Chem Biodivers; 2023 Aug; 20(8):e202300587. PubMed ID: 37332056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbohydrate chemistry in drug discovery.
    Galan MC; Benito-Alifonso D; Watt GM
    Org Biomol Chem; 2011 May; 9(10):3598-610. PubMed ID: 21409288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current strategies for diversity-oriented synthesis.
    Dandapani S; Marcaurelle LA
    Curr Opin Chem Biol; 2010 Jun; 14(3):362-70. PubMed ID: 20409744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments with multi-target drugs for Alzheimer's disease: an overview of the current discovery approaches.
    González JF; Alcántara AR; Doadrio AL; Sánchez-Montero JM
    Expert Opin Drug Discov; 2019 Sep; 14(9):879-891. PubMed ID: 31165654
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent developments in biological aspects of chalcones: the odyssey continues.
    Rani A; Anand A; Kumar K; Kumar V
    Expert Opin Drug Discov; 2019 Mar; 14(3):249-288. PubMed ID: 30773996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. exo-Glycal chemistry: general aspects and synthetic applications for biochemical use.
    Lin CH; Lin HC; Yang WB
    Curr Top Med Chem; 2005; 5(14):1431-57. PubMed ID: 16305538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Privileged structures: applications in drug discovery.
    DeSimone RW; Currie KS; Mitchell SA; Darrow JW; Pippin DA
    Comb Chem High Throughput Screen; 2004 Aug; 7(5):473-94. PubMed ID: 15320713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Overview on Glyco-Macrocycles: Potential New Lead and their Future in Medicinal Chemistry.
    Singh K; Tripathi RP
    Curr Med Chem; 2020; 27(20):3386-3410. PubMed ID: 30827227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marine actinomycetes as an emerging resource for the drug development pipelines.
    Zotchev SB
    J Biotechnol; 2012 Apr; 158(4):168-75. PubMed ID: 21683100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twelve-membered macrolactones: privileged scaffolds for the development of new therapeutics.
    Brzozowski RS; Wuest WM
    Chem Biol Drug Des; 2017 Feb; 89(2):169-191. PubMed ID: 27153932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational Bioactivity Fingerprint Similarities To Navigate the Discovery of Novel Scaffolds.
    Xiong GL; Zhao Y; Liu L; Ma ZY; Lu AP; Cheng Y; Hou TJ; Cao DS
    J Med Chem; 2021 Jun; 64(11):7544-7554. PubMed ID: 34008979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in biological activities of chalcones: a mini review.
    Singh P; Anand A; Kumar V
    Eur J Med Chem; 2014 Oct; 85():758-77. PubMed ID: 25137491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel anti-inflammatory drug-like compounds by aligning in silico and in vivo screening: the nitroindazolinone chemotype.
    Marrero-Ponce Y; Siverio-Mota D; Gálvez-Llompart M; Recio MC; Giner RM; García-Domènech R; Torrens F; Arán VJ; Cordero-Maldonado ML; Esguera CV; de Witte PA; Crawford AD
    Eur J Med Chem; 2011 Dec; 46(12):5736-53. PubMed ID: 22000935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in solid- and solution-phase methods for generating carbohydrate libraries.
    Sofia MJ; Silva DJ
    Curr Opin Drug Discov Devel; 1999 Jul; 2(4):365-76. PubMed ID: 19649965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marine-Derived Bioactive Peptides for Biomedical Sectors: A Review.
    Ruiz-Ruiz F; Mancera-Andrade EI; Iqbal HM
    Protein Pept Lett; 2017; 24(2):109-117. PubMed ID: 27491381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Bioactive Scaffolds Based on QSAR Models.
    Nakagawa T; Miyao T; Funatsu K
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29135084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Privileged structure-based combinatorial libraries targeting G protein-coupled receptors.
    Guo T; Hobbs DW
    Assay Drug Dev Technol; 2003 Aug; 1(4):579-92. PubMed ID: 15090254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.